Aflibercept in colorectal cancer: Indication of minor added benefit

Indication of considerable added benefit for overall survival, indications of greater harm from side effects

2013-07-11

(Press-News.org) The drug aflibercept (trade name: Zaltrap) has been approved in Germany since February 2013 in combination with a certain chemotherapy for adults with metastatic colorectal cancer in whom chemotherapy with oxaliplatin could not stop the disease from progressing. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy. According to this, considerable advantages in respect of overall survival are accompanied by major potential harm in the form of side effects. Overall, there is therefore an indication of a minor added benefit of aflibercept.

Aflibercept complements chemotherapy

Aflibercept in combination with a chemotherapy consisting of irinotecan/5-fluorouracil/folinic acid (FOLFIRI) was compared with FOLFIRI alone. The approval study (VELOUR), which compared the treatment "aflibercept plus FOLFIRI" with the treatment "placebo plus FOLFIRI", was available for the benefit assessment. This was a randomized and double-blind study, i.e. the patients were assigned randomly to one of the two treatment groups, and neither the patients nor the doctors knew whether aflibercept with FOLFIRI or FOLFIRI alone was used.

A total of 178 centres in Europe, America, Australia, New Zealand, South Africa and Korea took part in this multinational study: The participants were 1226 adults with adenocarcinoma of the colon or rectum who had recurrence after failure of a chemotherapy containing the drug oxaliplatin.

Overall survival: indication of considerable added benefit

Half of the patients who received FOLFIRI chemotherapy alone had died after 12 months. Half of the patients who received aflibercept in combination with FOLFIRI chemotherapy had died after 13 to 14 months. This means that life expectancy increased by 1 to 2 months on average (median). For overall survival, this led to an indication of an added benefit with the extent "considerable" for the combination of aflibercept with FOLFIRI in comparison with FOLFIRI alone.

The manufacturer's dossier did not provide any results, or any results that could be used, on symptoms and complaints (morbidity) and health-related quality of life. Hence an added benefit of aflibercept in comparison with the appropriate comparator therapy for these outcome categories is not proven.

Side effects: indications of greater harm

Serious events and severe adverse events (e.g. infection, diseases of organs, metabolism, blood and lymph system) as well as treatment discontinuations due to severe adverse events were more frequent during the treatment with aflibercept than during the treatment with FOLFIRI alone in all age groups.

In summary, there is an indication of greater harm with major extent from the treatment with aflibercept plus FOLFIRI in comparison with FOLFIRI alone for several outcomes of the category side effects.

Overall, indication of minor added benefit

Overall, positive effects of aflibercept are accompanied by negative effects with the same certainty of results: the indication of a considerable added benefit in mortality (overall survival) has to be weighed up against the indications of greater harm with major extent regarding side effects. IQWiG therefore downgrades the extent of the added benefit of aflibercept in comparison with the appropriate comparator therapy from "considerable" to "minor".

IQWiG published a first assessment of aflibercept (trade name: Eylea) on 15th March 2013. This dealt with a different therapeutic indication, however, namely the "treatment of wet age-related macular degeneration (AMD)".

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturer's dossier and IQWiG's assessment, the G-BA conducts a commenting procedure, which may provide further information and result in a change to the benefit assessment. The G-BA then decides on the extent of the added benefit, thus completing the early benefit assessment.

### An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website gesundheitsinformation.de, published by IQWiG, provides easily understandable and brief German-language information on aflibercept.

The G-BA website contains both general English-language information on benefit assessment pursuant to §35a Social Code Book (SGB) V and specific German-language information on the assessment of aflibercept.

ELSE PRESS RELEASES FROM THIS DATE:

Solar tsunami used to measure Sun's magnetic field

2013-07-11

A solar tsunami observed by NASA's Solar Dynamics Observatory (SDO) and the Japanese Hinode spacecraft has been used to provide the first accurate estimates of the Sun's magnetic field. Solar tsunamis are produced by enormous explosions in the Sun's atmosphere called coronal mass ejections (CMEs). As the CME travels out into space, the tsunami travels across the Sun at speeds of up to 1000 kilometres per second. Similar to tsunamis on Earth, the shape of solar tsunamis is changed by the environment through which they move. Just as sound travels faster in water than in ...

ID got you, under the skin

2013-07-11

Forget fingerprints or iris recognition, the next big thing in biometrics will be a thermal imaging scan that maps the blood vessels under the skin of your face for instantaneous face recognition that would be almost impossible to spoof. Writing in a forthcoming issue of the International Journal of Computational Intelligence Studies, a team at Jadavpur University in Kolkata, India, explains how the pattern of blood vessels just beneath the skin of our faces is as unique as a fingerprint, iris or other characteristic. It can be revealed easily with an infra-red thermal ...

Molecular discovery puts cancer treatment in a new perspective

2013-07-11

Researchers from the University of Copenhagen and the National Institutes of Health have obtained ground-breaking new knowledge about proteases - important enzymes which, among other things, play a role in the development of cancer cells. The findings may be significant for the development of cancer drugs, and have just been published in Journal of Biological Chemistry. Cancer cells can exploit an over-production of proteases to force their way into the body. In a joint effort with the National Institutes of Health, a group of researchers from the University of Copenhagen ...

Discovery of a strange new snow scorpionfly species in Alaska helped by Facebook

2013-07-11

Researchers from the University of Alaska Fairbanks (Derek Sikes and Jill Stockbridge) discovered a strange new insect on Prince of Wales Island, Alaska. It belongs to an enigmatic group that might help scientists understand the evolutionary origin of the Fleas. The new species belongs to the insect order Mecoptera which includes the scorpionflies, hangingflies, and snow scorpionflies. The description has been published recently in the open access journal ZooKeys. VIDEO: ...

NIST shows how to make a compact frequency comb in minutes

2013-07-11

Laser frequency combs-high-precision tools for measuring different colors of light in an ever-growing range of applications such as advanced atomic clocks, medical diagnostics and astronomy-are not only getting smaller but also much easier to make. Physicists at the National Institute of Standards and Technology (NIST) can now make the core of a miniature frequency comb in one minute.* Conventional microfabrication techniques, by contrast, may require hours, days or even weeks. The NIST technique involves laser machining of a quartz rod (a common type of glass) to ...

Acceptance predicts satisfaction in later life

2013-07-11

When older adults lose control as they move into residential care, they adapt and accept what cannot be changed in order to stay happy. According to a new study, by Jaclyn Broadbent, Shikkiah de Quadros-Wander and Jane McGillivray from Deakin University in Australia, when it comes to satisfaction in later life the ability to accept what cannot be changed is as important as the feeling of being able to exert control. Their work is published online in Springer's Journal of Happiness Studies. Ageing with satisfaction has been linked to maintaining a sense of control into ...

Autism Speaks collaborative releases first full genome sequencing for autism

2013-07-11

NEW YORK, N.Y. -- A collaborative formed by Autism Speaks, the world's leading autism science and advocacy organization, has found full genome sequencing examining the entire DNA code of individuals with autism spectrum disorder (ASD) and their family members to provide the definitive look at the wide ranging genetic variations associated with ASD. The study published online today in American Journal of Human Genetics, reports on full genome sequencing on 32 unrelated Canadian individuals with autism and their families, participants in the Autism Speaks Autism Genetic Resource ...

Understanding bulls' gene-rich Y chromosomes may improve herd fertility

2013-07-11

The Y chromosomes of cattle have more genes and are more active than the Y chromosomes of other primates, according to researchers. This discovery may help biologists better understand how cattle and other mammals evolved, as well as help animal breeders and farmers better maintain and enhance fertility in the cattle industry, said Wansheng Liu, associate professor of animal genomics, Penn State. "Low fertility is a big problem for the dairy and beef industry," Liu said. "In the past 60 years, we paid more attention to milk, or beef production as a sign of herd success, ...

Whole chickens from farmers markets may have more pathogenic bacteria

2013-07-11

Raw, whole chickens purchased from farmers markets throughout Pennsylvania contained significantly higher levels of bacteria that can cause foodborne illness compared to those purchased from grocery stores in the region, according to a small-scale study by researchers in Penn State's College of Agricultural Sciences Of 100 whole chickens purchased from farmers markets, 90 percent tested positive for Campylobacter and 28 percent harbored Salmonella. By comparison, during the same period, 20 percent of raw, whole, organic chickens purchased from grocery stores were found ...

Mexican American youth show signs of metabolic syndrome: Early screening critical

2013-07-11

Mexican American children are experiencing substantial burdens of obesity, pre-diabetes, and other health problems which historically would have been expected to develop much later in life. The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age. Directed by Texas Biomed scientist Ravindranath Duggirala, Ph.D., in collaboration with scientists from UT Health Science Center at San Antonio and other institutions, the results of the study were published ...

Aflibercept in colorectal cancer: Indication of minor added benefit

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: